Oisin Biotechnologies

📍 Seattle, United States🗓 Founded 2014👥 16 employees💰 Last funded Oct 2021
Biotechnology Research🌐 oisinbio.com
Website LinkedIn
Oisin Biotechnologies is a longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases. When cells detect that they have been irreversibly damaged, they enter a non-dividing condition known as cell-cycle arrest, or senescence. It’s believed this occurs to prevent cells from going rogue and turning cancerous. Ideally, they should die by the process known as apoptosis, but as we age, more and more frequently they don’t. They become zombie cells – unable to kill themselves or resume normal function. Senescent cells secrete molecules that cause inflammation in an effort to attract immune cells that would usually clear them. But for reasons that are not fully known, as we age, persistently senescent cells accumulate, leading to a vast number of age-related diseases. Oisín Biotechnologies is developing a highly precise, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces negative effects of aging pathologies and also extends median lifespan and survival.
6
Total investors
1
Early stage
4
Mid stage
1
Late stage
2014
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
6
Investor activity2016–2021 · investors recorded per year
20161201832019120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Oisin Biotechnologies?
Oisin Biotechnologies has 6 investors on record on gritt.io, including 1 early-stage backers, 4 mid-stage and 1 late-stage investors.
When did Oisin Biotechnologies last raise funding?
The most recent investment in Oisin Biotechnologies recorded on gritt.io was in October 2021.
When was Oisin Biotechnologies founded?
Oisin Biotechnologies was founded in 2014.
What industry is Oisin Biotechnologies in?
Oisin Biotechnologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Oisin Biotechnologies based?
Oisin Biotechnologies is headquartered in Seattle, United States.